Last update 08 Nov 2025

MK-6913

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
MK 6913
Target
ERβ
Action
agonists
Mechanism
ERβ agonists(Estrogen receptor beta agonists)
Therapeutic Areas
Cardiovascular DiseasesOther Diseases
Active Indication-
Inactive Indication
Hot FlashesVascular DiseasesVasomotor symptom
Originator Organization
Karo Bio USA, Inc.Karo Bio USA, Inc.
Active Organization-
Inactive Organization
Karo Bio USA, Inc.Karo Bio USA, Inc.Merck Sharp & Dohme LLCMerck GmbH
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with MK-6913
NCT01015677
/ TerminatedPhase 2
A Phase IIa, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Examine MK-6913 for the Treatment of Vasomotor Symptoms in Postmenopausal Women
100 Clinical Results associated with MK-6913
Login to view more data
100 Translational Medicine associated with MK-6913
Login to view more data
100 Patents (Medical) associated with MK-6913
Login to view more data
100 Deals associated with MK-6913
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hot FlashesPhase 2-
Merck Sharp & Dohme LLC
17 Dec 2009
Vasomotor symptomPhase 2-
Merck Sharp & Dohme LLC
17 Dec 2009
Vascular DiseasesPhase 2-
Karo Bio USA, Inc.Karo Bio USA, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT01015677 (6913-004, CTgov)
Phase 2
Hot Flashes | Vasomotor symptom
99
Placebo to 17-β estradiol+MK-6913
(MK-6913 75 mg)
oqqjdspikj(aiohgrpopj) = bmojogbgxs umknocytyg (jpmdqlnnyu, bbbckzqsra - xmfhxzqmrh)
View more
-
04 May 2016
Placebo to MK-6913+17-β estradiol
(17-β Estradiol 1 mg)
oqqjdspikj(aiohgrpopj) = bzjppgkbld umknocytyg (jpmdqlnnyu, vwyguinwnb - axiohcqcsp)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free